KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl-chromane

被引:45
作者
Loussouarn, G
Charpentier, F
Mohammad-Panah, R
Kunzelmann, K
Baró, I
Escande, D
机构
[1] Hop Hotel Dieu, INSERM, CJF 9601, Lab Physiopathol & Pharmacol Cellulaires & Mol, F-44093 Nantes, France
[2] Univ Freiburg, Inst Physiol, D-7800 Freiburg, Germany
关键词
D O I
10.1124/mol.52.6.1131
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mutations in the KvLQT1 gene are the cause for the long QT syndrome [Circulation 94:1996-2012 (1996)]. Coexpression of KvLQT1 in association with the channel regulator protein IsK produces a K+ current with characteristics reminiscent of the slow component of the delayed rectifier in cardiac myocytes. We explored the pharmacological properties of trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-1,2-dimethylchromane (293B), a chromanol compound, on the K+ current produced by direct intranuclear injection of KvLQT1 and IsK cDNA plasmids in COS-7 cells. Injected cells were recorded by means of the whole-cell and cell-attached patch-clamp configurations under chloride-free conditions. Cells injected with KvLQT1 cDNA alone exhibited a fast-activating outward K+ current, whereas cells coinjected with KvLQT1 plus IsK cDNAs exhibited a time-dependent outward current with slower activation kinetics. The chromanol 293B blocked the K+ current related to KvLQT1 expression in both the absence or presence of IsK. The IC50 value for 293B to block KvLQT1-related current was not significantly modified by the presence of IsK (9.9 mu M in the absence of IsK versus 9.8 mu M in its presence). The block produced by 293B was strongly voltage-dependent inasmuch as it was close to 0 at -80 mV and occurred during a depolarizing voltage step. The time constants for the drug to block the current were in the same order of magnitude as activation kinetics of the current. Kinetics for drug unblock at the holding potential were much faster, in the order of a few tenths of a msec. KvLQT1 currents recorded in the cell-attached configuration were also blocked by externally applied 293B, suggesting that the compound penetrated the cell to block the channel. Cromakalim, another chromanol compound, also blocked KvLQT1 currents. Our results show that the chromanol compound 293B is targeted to KvLQT1 channels but not to the IsK regulator.
引用
收藏
页码:1131 / 1136
页数:6
相关论文
共 26 条
  • [1] THE PROTEIN ISK IS A DUAL ACTIVATOR OF K+ AND CL- CHANNELS
    ATTALI, B
    GUILLEMARE, E
    LESAGE, F
    HONORE, E
    ROMEY, G
    LAZDUNSKI, M
    BARHANIN, J
    [J]. NATURE, 1993, 365 (6449) : 850 - 852
  • [2] K(v)LQT1 and IsK (minK) proteins associate to form the I-Ks cardiac potassium current
    Barhanin, J
    Lesage, F
    Guillemare, E
    Fink, M
    Lazdunski, M
    Romey, G
    [J]. NATURE, 1996, 384 (6604) : 78 - 80
  • [3] Busch A. E., 1997, Biophysical Journal, V72, pA50
  • [4] THE POTASSIUM CHANNEL OPENER CROMAKALIM (BRL-34915) ACTIVATES ATP-DEPENDENT K+ CHANNELS IN ISOLATED CARDIAC MYOCYTES
    ESCANDE, D
    THURINGER, D
    LEGUERN, S
    CAVERO, I
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (02) : 620 - 625
  • [5] POTASSIUM CHANNEL OPENERS ACT THROUGH AN ACTIVATION OF ATP-SENSITIVE K+ CHANNELS IN GUINEA-PIG CARDIAC MYOCYTES
    ESCANDE, D
    THURINGER, D
    LEGUERN, S
    COURTEIX, J
    LAVILLE, M
    CAVERO, I
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1989, 414 (06): : 669 - 675
  • [6] SITE-SPECIFIC MUTATIONS IN A MINIMAL VOLTAGE-DEPENDENT K+ CHANNEL ALTER ION SELECTIVITY AND OPEN-CHANNEL BLOCK
    GOLDSTEIN, SAN
    MILLER, C
    [J]. NEURON, 1991, 7 (03) : 403 - 408
  • [7] RATE-DEPENDENT PROLONGATION OF CARDIAC ACTION-POTENTIALS BY A METHANESULFONANILIDE CLASS-III ANTIARRHYTHMIC AGENT - SPECIFIC BLOCK OF RAPIDLY ACTIVATING DELAYED RECTIFIER K+-CURRENT BY DOFETILIDE
    JURKIEWICZ, NK
    SANGUINETTI, MC
    [J]. CIRCULATION RESEARCH, 1993, 72 (01) : 75 - 83
  • [8] Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements
    Lee, MP
    Hu, RJ
    Johnson, LA
    Feinberg, AP
    [J]. NATURE GENETICS, 1997, 15 (02) : 181 - 185
  • [9] LESAGE F, 1993, RECEPTOR CHANNEL, V1, P143
  • [10] A NEW CLASS OF INHIBITORS OF CAMP-MEDIATED CL- SECRETION IN RABBIT COLON, ACTING BY THE REDUCTION OF CAMP-ACTIVATED K+ CONDUCTANCE
    LOHRMANN, E
    BURHOFF, I
    NITSCHKE, RB
    LANG, HJ
    MANIA, D
    ENGLERT, HC
    HROPOT, M
    WARTH, R
    ROHM, W
    BLEICH, M
    GREGER, R
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1995, 429 (04): : 517 - 530